Sponsor Check › Sponsor group
5 issuers linked to one sponsor · New York, NY
Grouped because: 9 shared people, same business address (2 issuers), similar issuer names (4) · 2 issuers also list a director who sits on many unrelated issuers (not used to group) (automatic match from the filings) ·Not the same sponsor? Request a correction
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing in this group: Oct 8, 2019 · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
No SEC search has run yet for this sponsor group.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.
12 of 19 offerings report sales commissions totalling $7,216,887; 0 report finder's fees; 3 report proceeds to related persons totalling $1,456,761. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Oct 8, 2019 D File 021-350641 | $0 | $0 | $0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. | None no CRD number reported |
| EDGAR ↗ | Jul 10, 2019 D/A File 021-343016 | $688,887 | $0 | $0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. | Alexander Capital, LP BrokerCheck CRD 40077 ↗ Brookline Capital Markets, A division of Arcadia Securities, LLC BrokerCheck CRD 44656 ↗ |
| EDGAR ↗ | May 16, 2019 D File 021-339798 | $221,150 | $0 | $0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. | Alexander Capital, LP BrokerCheck CRD 40077 ↗ Brookline Capital Markets, A division of CIM Securities, LLC BrokerCheck CRD 120852 ↗ |
| EDGAR ↗ | Dec 10, 2018 D/A File 021-324029 | $563,861 | $0 | $0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. | Alexander Capital, LP BrokerCheck CRD 40077 ↗ |
| EDGAR ↗ | Oct 6, 2017 D File 021-296142 | $584,500 | $0 | $0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. | Alexander Capital, LP BrokerCheck CRD 40077 ↗ |
| EDGAR ↗ | Jun 19, 2014 D File 021-219502 | $1,069,458 | $0 | $0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jun 4, 2014 D File 021-218540 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 22, 2014 D File 021-217828 | $1,806,133 | $0 | $0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jan 21, 2014 D/A File 021-209458 | $663,672 | $0 | $0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. | Recipient Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Oct 8, 2013 D File 021-204170 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 4, 2013 D File 021-202314 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 7, 2013 D File 021-197621 | $18,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jun 6, 2013 D/A File 021-181601 | $495,550 | $0 | $225,000 The amount set forth above covers the annual compensation for one of the persons set forth in item 3. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Mar 19, 2013 D File 021-193542 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 14, 2013 D File 021-190210 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 31, 2012 D File 021-189157 | $618,174 | $0 | $600,000 (est.) | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Nov 3, 2011 D File 021-168172 | $75,000 (est.) | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Oct 17, 2011 D File 021-167352 | $412,502 | $0 | $631,761 (est.) To be used to pay salaries. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Apr 30, 2009 D File 021-130594 | $0 | $0 | $0 (est.) The General Partner (or its affiliate) is entitled to receive an annual management fee in an amount equal to a specified percentage of assets under management. | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across all 5 issuers in this group — every filing in our index, latest filing per offering (SEC file number).
0 recorded documents and 0 ownership records matched to Relmada Therapeutics in the sources searched.
Not found in sources searched as of Oct 23, 2026, 8:59 PM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Florida DOR NAL roll (Hillsborough 39) roll year 2026 — loaded Oct 23, 2026, 8:54 PM ET; Florida DOR NAL roll (Dade 23) roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET. Not yet searched for this group (queued): NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.
Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Hillsborough County FL (recorded documents from Oct 14, 2026 forward; ownership from FL DOR roll 2026); Cook County IL (assessor ownership and deed/sale records, looked up per issuer when its page is viewed); Harris County TX and Dallas County TX (assessor ownership rolls only, 2026 roll; no deed, mortgage or sale records); Miami-Dade County FL (ownership from FL DOR roll only; Clerk recorded documents not yet searched). Recorder indexes for TX, AZ, IL and WA counties, mortgages and liens outside NYC and FL, lis pendens and foreclosure notices everywhere, Miami-Dade County FL recorded documents, Maricopa County AZ, King County WA, Salt Lake County UT, and all other counties are not yet searched. Last refresh by source: Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Dade 23) Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Hillsborough 39) Oct 23, 2026, 8:54 PM ET. NYC and Cook County are looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 2:18 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.
Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.
| Source | Issuer | Linked by | Location | Industry | Filings | Sold (max) | Investors | Min. investment (latest filing) | Active |
|---|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Ardana Healthcare Fund LP | shared people | New York, NY | Pooled Investment Fund | 1 | $1,250,000 | 2 | $1,000,000 | 2009–2009 |
| EDGAR ↗ | Actinium Pharmaceuticals, Inc. | shared people, same business address, similar issuer names, director listed on many unrelated issuers (not used to group) | New York, NY | Pharmaceuticals | 3 | $5,141,450 | 108 | $3,000 | 2011–2012 |
| EDGAR ↗ | Relmada Therapeutics, Inc. | shared people, similar issuer names | NEW YORK, NY | Biotechnology | 4 | $15,051,110 offering $15,051,110 · similar: $2,000,000–$19,999,994 | 225 similar: 2–16 | $100,000 similar: $10,000–$50,000 | 2012–2014 |
| EDGAR ↗ | Actinium Pharmaceuticals, Inc. | shared people, same business address, similar issuer names, director listed on many unrelated issuers (not used to group) | NEW YORK, NY | Pharmaceuticals | 6 | $6,636,720 offering $6,636,720 · similar: $1,694,259–$16,000,000 | 348 similar: 1–13 | $5,000 similar: $10,000–$55,000 | 2013–2014 |
| EDGAR ↗ | RELMADA THERAPEUTICS, INC. | shared people, similar issuer names | NEW YORK, NY | Biotechnology | 10 | $10,694,588 offering $825,750 · similar: $2,000,000–$19,999,994 | 382 similar: 2–16 | $10,000 similar: $10,000–$50,000 | 2014–2019 |
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
| Source | Filed | Issuer | Form | Industry | Offered | Sold |
|---|---|---|---|---|---|---|
| EDGAR ↗ | Oct 8, 2019 | RELMADA THERAPEUTICS, INC. | D | Biotechnology | $825,750 | $825,750 |
| EDGAR ↗ | Jul 10, 2019 | RELMADA THERAPEUTICS, INC. | D/A | Biotechnology | $10,000,000 | $8,432,437 |
| EDGAR ↗ | Jun 27, 2019 | RELMADA THERAPEUTICS, INC. | D | Biotechnology | $10,000,000 | $8,002,248 |
| EDGAR ↗ | May 16, 2019 | RELMADA THERAPEUTICS, INC. | D | Biotechnology | $10,000,000 | $3,414,505 |
| EDGAR ↗ | Dec 10, 2018 | RELMADA THERAPEUTICS, INC. | D/A | Biotechnology | $10,000,000 | $5,834,407 |
| EDGAR ↗ | Nov 13, 2018 | RELMADA THERAPEUTICS, INC. | D/A | Biotechnology | $10,000,000 | $4,629,507 |
| EDGAR ↗ | Oct 22, 2018 | RELMADA THERAPEUTICS, INC. | D | Biotechnology | $10,000,000 | $3,279,998 |
| EDGAR ↗ | Oct 6, 2017 | RELMADA THERAPEUTICS, INC. | D | Biotechnology | $6,890,000 | $6,890,000 |
| EDGAR ↗ | Jun 19, 2014 | RELMADA THERAPEUTICS, INC. | D | Biotechnology | $10,694,588 | $10,694,588 |
| EDGAR ↗ | Jun 4, 2014 | RELMADA THERAPEUTICS, INC. | D | Biotechnology | $0 | $0 |
| EDGAR ↗ | May 22, 2014 | Relmada Therapeutics, Inc. | D | Biotechnology | $15,051,110 | $15,051,110 |
| EDGAR ↗ | Jan 21, 2014 | Actinium Pharmaceuticals, Inc. | D/A | Pharmaceuticals | $6,636,720 | $6,636,720 |
| EDGAR ↗ | Jan 7, 2014 | Actinium Pharmaceuticals, Inc. | D | Pharmaceuticals | $6,000,000 | $3,325,860 |
| EDGAR ↗ | Oct 8, 2013 | Actinium Pharmaceuticals, Inc. | D | Pharmaceuticals | Indefinite | $0 |
| EDGAR ↗ | Sep 4, 2013 | Actinium Pharmaceuticals, Inc. | D | Pharmaceuticals | Indefinite | $0 |
| EDGAR ↗ | Jun 7, 2013 | Relmada Therapeutics, Inc. | D | Pharmaceuticals | $750,000 | $180,000 |
| EDGAR ↗ | Jun 6, 2013 | Relmada Therapeutics, Inc. | D/A | Pharmaceuticals | $8,000,000 | $4,955,500 |
| EDGAR ↗ | Mar 19, 2013 | Actinium Pharmaceuticals, Inc. | D | Pharmaceuticals | Indefinite | $0 |
| EDGAR ↗ | Jan 14, 2013 | Actinium Pharmaceuticals, Inc. | D | Pharmaceuticals | Indefinite | $0 |
| EDGAR ↗ | Dec 31, 2012 | Actinium Pharmaceuticals, Inc. | D | Pharmaceuticals | $15,000,000 | $5,141,450 |
| EDGAR ↗ | Jul 23, 2012 | Relmada Therapeutics, Inc. | D | Pharmaceuticals | $6,000,000 | $3,008,000 |
| EDGAR ↗ | Nov 3, 2011 | Actinium Pharmaceuticals, Inc. | D | Pharmaceuticals | $750,000 | $364,000 |
| EDGAR ↗ | Oct 17, 2011 | Actinium Pharmaceuticals, Inc. | D | Pharmaceuticals | $6,000,000 | $4,125,025 |
| EDGAR ↗ | Apr 30, 2009 | Ardana Healthcare Fund LP | D | Pooled Investment Fund | Indefinite | $1,250,000 |
Activity: 0 new offerings in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Oct 8, 2019. Industry history, as reported on each offering's latest filing: Previous offerings: Pooled Investment Fund (2009), Pharmaceuticals (2011–2014). Latest offering: Biotechnology (2014–2019; most recent Oct 8, 2019).
| Name | Roles | Issuers here | First → last listed |
|---|---|---|---|
| Sergio Traversa | Executive Officer, Director | 5 | Apr 30, 2009 → Oct 8, 2019 |
| Sandesh Seth | Director | 4 | Dec 31, 2012 → Jun 19, 2014 |
| Nabil M. Yazgi | Director | 2 | May 22, 2014 → Jun 19, 2014 |
| Douglas Beck | Executive Officer | 2 | May 22, 2014 → Jun 19, 2014 |
| Shreeram Agharkar | Director | 2 | May 22, 2014 → Jun 19, 2014 |
| Eliseo O. Salinas | Executive Officer | 2 | May 22, 2014 → Jun 19, 2014 |
| David Nicholson | Director | 2 | Oct 17, 2011 → Jan 21, 2014 |
| Dragan Cicic | Executive Officer, Director | 2 | Oct 17, 2011 → Jan 21, 2014 |
| Jack V. Talley | Executive Officer, Director | 2 | Dec 31, 2012 → Jan 14, 2013 |
| Maged Shenouda | Director | 1 | Oct 6, 2017 → Oct 8, 2019 |
| Charles Casamento | Director | 1 | Oct 6, 2017 → Oct 8, 2019 |
| Paul Kelly | Director | 1 | Oct 6, 2017 → Oct 8, 2019 |
| Ottavio Vitolo | Executive Officer | 1 | Oct 22, 2018 → Oct 8, 2019 |
| Chuck Ence | Executive Officer | 1 | Oct 8, 2019 → Oct 8, 2019 |
| Richard I. Steinhart | Director | 1 | Jan 7, 2014 → Jan 21, 2014 |
| Kaushik J. Dave | Executive Officer, Director | 1 | Oct 8, 2013 → Jan 21, 2014 |
| Enza Guagenti | Executive Officer | 1 | Dec 31, 2012 → Dec 31, 2012 |
| Rosemary Mazanet | Director | 1 | Oct 17, 2011 → Dec 31, 2012 |
| Najib Babul | Executive Officer, Director | 1 | Jul 23, 2012 → Jul 23, 2012 |
| Richard Sherman | Executive Officer, Director | 1 | Oct 17, 2011 → Nov 3, 2011 |
| Sushant Kumar | Executive Officer | 1 | Apr 30, 2009 → Apr 30, 2009 |
Not yet searched. Sources to be searched: SEC Investment Adviser Information Reports — Form ADV data for SEC-registered advisers and exempt reporting advisers (file dated 2026-10-02); SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet searched.
Sources to be searched: the sponsor's website (none on record yet; a sponsor's website is known only from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim or Form ADV Item 1.I of its matched adviser — we never look it up elsewhere) for Meta Pixel ids and Facebook / Instagram page links; Meta Ad Library API: not yet searched (API access pending). We never read facebook.com or instagram.com; readers get a link to Meta's public Ad Library instead.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
No corrections have been requested for this page.
Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.
Add a sourced explanation next to any fact. Reviewed before publishing.